Arrowhead Pharmaceuticals Inc. (ARWR)

Overview News Price History Option Chain Why ARWR Down? Discussions Forecast Stock Split

Why is Arrowhead Pharmaceuticals Inc. (ARWR) Stock down?

We've noticed a 6.10% decline in Arrowhead Pharmaceuticals Inc. (ARWR) stock during the 2024-04-25 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!

30 Nov, 2023:

Arrowhead Pharmaceuticals Inc. Stock (ARWR) dropped by 26.85% from $28.98 to $21.20 in the trading on Thursday November 30, 2023. The reasons why ARWR stock down today include:

**Net loss **: Arrowhead Pharmaceuticals, Inc. today announced its financial results for the fourth quarter and full year ended September 30, 2023. Arrowhead announced a net loss of $205.3 million for the fiscal year ended September 30, 2023, compared to a net loss of $176.1 million for the previous fiscal year.
Missed results: Arrowhead Pharmaceuticals reported fiscal year GAAP EPS of -$1.92, missing the consensus by $0.41. Revenue of $240.73 million, slightly down from $243.2 million in the previous year. Revenue figures missed the consensus by $22.85M.
Increase in expenses: Arrowhead Pharmaceuticals Inc's fiscal year was marked by significant investment in research and development (R&D), with expenses rising to $353.2 million from $297.3 million in the previous year. This increase reflects the company's commitment to advancing its pipeline of RNAi therapeutics.

07 Jul, 2023:

Arrowhead Pharmaceuticals Stock (ARWR) stock decreased 3.53% to $33.32 due to some notable insider selling from the biotech’s senior leadership, namely, Tracie Oliver, ARWR’s Chief Commercial Officer.

https://seekingalpha.com/news/3986290-why-did-arrowhead-stock-dip-today